GLG Partners’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-125,000
Closed -$5.74M 552
2015
Q1
$5.74M Buy
+125,000
New +$3.74M 0.19% 150

GLG Partners's HPTX Position: Q2 2015 in Review

GLG Partners sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 125,000 shares — an estimated $5.74M sold.

GLG Partners first reported a position in HPTX in Q1 2015 and held it in 1 quarter. The position peaked at $5.74M in Q1 2015. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

  • GLG Partners reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • GLG Partners sold 125,000 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $5.74M.
  • GLG Partners first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q1 2015 and held it in 1 quarter.
  • GLG Partners's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $5.74M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on GLG Partners's 13F filing for Q2 2015, filed 14 Aug 2015.